INNOVEOX gets Charles Rosier as new Partner and TOTAL EP as first client - Afrik-news.com : Africa news, Maghreb news - The african daily newspaper
The drug project charles rosier (afrik-news.com/article19454.html) funded was for the treatment of stroke known to cause spinal cord problems. He funded Mapreg, a laboratory based in Paris, in order to conduct research concerning stroke, depression and other serious ailments. Being one of his healthcare projects, Charles Rosier invested in Mapreg, a pharmaceutical company led by Professor Etienne Baulieu.
Educational Attainment of Charles Rosier
Charles Rosier successfully was awarded his first scientific Baccalaureate degree (equal to A-levels in the UK). To get more training and to prepare for further French education, Charles Rosier studied for another two years. Big organisations see him to be a well-experienced banker, who is able to hold various positions in the industry.
Charles Rosier studied at Fenelon Sainte-Marie and earned his scientific degree in 1991. He developed a partnership with BGT Pactual Bank until 2010. He didn’t settle for just one job but took other positions in the market while an investment banker. In an exceptional private school named Integrale, Charles Rosier spent two years in class to get ready for ESCP Europe.
Charles Rosier and His Profession
The French-speaking markets of France, Belgium, as well as Quebec were managed by Charles Rosier when he worked at UBS Warburg. He finally became a member of BTG Pactual in August 2010. He became partners with an investment bank in Latin America: BTG Pactual. In 1999, Charles Rosier was offered a great job at Goldman Sachs (GMS). He became their Managing Director.